Skip to main content

27 publications

Name Date Type Actions

Programme de rachat - June 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

02/07/2020 Monthly communication regarding buyback programs

Vetoquinol is moving forward with the acquisition of Profender® and Drontal® and related pipeline assets following communication from the European commission

June 9th, 2020 (Lure, France) - The European Commission (EC) has approved, under the EU merger Regulation, the proposed acquisition of Bayer’s Animal Health Division by Elanco Animal Health.

09/06/2020 Public releases

Programme de rachat - May 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

04/06/2020 Monthly communication regarding buyback programs

Programme de rachat - April 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

06/05/2020 Monthly communication regarding buyback programs

Dominique Derveaux appointed Group Chief Operations Officer Effective April 1, 2020, Vetoquinol’s Board of Directors has appointed Dominique Derveaux Group Chief Operations Officer. In this capacity, he will run the Business, Marketing & Medical, Industrial, and Information Systems departments. He will report to Vetoquinol CEO Matthieu Frechin.

28/04/2020 Public releases

Availability of the 2019 universal registration document

Vetoquinol informs that it has filed its 2019 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 23, 2020.

23/04/2020 Public releases

Q1 2020 sales €103.4 million (Up 13.7%)

Vetoquinol Group sales for Q1 2020 amounted to €103.4 million, up 13.7% as reported and up 13.4% at constant exchange rates.

16/04/2020 Public releases

Programme de rachat - March 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

06/04/2020 Monthly communication regarding buyback programs

Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mars 2020)

Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers 

30/03/2020 Monthly communication regarding buyback programs

2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales)

At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon.

26/03/2020 Public releases